BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 59 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $17,000 | +21.4% | 4,167 | 0.0% | 0.00% | – |
| Q3 2021 | $14,000 | -12.5% | 4,167 | -1.0% | 0.00% | – |
| Q2 2021 | $16,000 | 0.0% | 4,211 | +1.1% | 0.00% | – |
| Q1 2021 | $16,000 | -15.8% | 4,167 | -0.6% | 0.00% | – |
| Q4 2020 | $19,000 | -81.7% | 4,194 | -32.0% | 0.00% | -100.0% |
| Q3 2020 | $104,000 | +50.7% | 6,167 | +0.2% | 0.00% | 0.0% |
| Q2 2020 | $69,000 | +263.2% | 6,155 | +48.6% | 0.00% | – |
| Q1 2020 | $19,000 | – | 4,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 189,935 | $311,494 | 0.08% |
| ABNER HERRMAN & BROCK LLC | 280,000 | $459 | 0.07% |
| Weaver Consulting Group | 65,947 | $108,153 | 0.06% |
| S.C. Financial Services, Inc. | 25,372 | $41,610 | 0.03% |
| JMAC ENTERPRISES LLC | 40,430 | $66,305 | 0.02% |
| Weaver Consulting Group | 53,500 | $10,047 | 0.01% |
| IFP Advisors, Inc | 26,650 | $139 | 0.00% |
| Bangor Savings Bank | 4,000 | $7 | 0.00% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 3,000 | $4,920 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 19,098 | $31,321 | 0.00% |